Omeprazole Tablet, Delayed Release
Product Images NDC 68001-441

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Omeprazole (NDC 68001-441). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container Bottle Label (Omeprazole Delayed Release Tablets 20 mg 14 Ct Bottle Label)

Omeprazole 20 mg delayed-release tablets label by BluePoint Laboratories. The label includes the NDC 68001-441-55, states the product treats frequent heartburn, and contains 14 tablets. It indicates the tablets are acid reducers with a recommended treatment course of up to 14 days. Additional drug facts and warnings appear on the label.*

FDA Label Image

Omeprazole Delayed Release Tablets 20 mg 14 Ct Cartonl

Label for Omeprazole Delayed-Release Tablets 20 mg by BluePoint Laboratories. The carton includes directions for use, drug facts including active ingredient and purpose, warnings, and usage instructions. The package contains 14 tablets for oral use as an acid reducer, with one 14-day course of treatment suggested. The label includes barcodes, lot and expiration date fields, and mentions the product is made in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.